Expression in Escherichia coli, refolding, and purification of human procathepsin K, an osteoclast-specific protease

被引:29
作者
D'Alessio, KJ
McQueney, MS
Brun, KA
Orsini, MJ
Debouck, CM
机构
[1] SmithKline Beecham Pharmaceut, Dept Prot Biochem, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Mol Biol, King Of Prussia, PA 19406 USA
[3] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
关键词
D O I
10.1006/prep.1998.1013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have constructed and optimized a high yielding Escherichia coli expression system to produce glycosylation-free human procathepsin K and have developed conditions for refolding this enzyme. Recombinant human procathepsin K (EC 3.4.22.38) was expressed in E, coli, refolded from inclusion bodies, and further purified by Superdex 75 size-exclusion chromatography, Purified procathepsin K had a [MH](+) of 35,063 Da which is in agreement with the predicted mass of the construct, Amino-terminal sequence analysis matched the predicted sequence with no secondary sequence detected, Purified procathepsin K activated under autocatalytic conditions to a final specific activity of 23 mu mol 7-amido-4-methylcoumarin liberated/min/mg of enzyme using the fluorescent peptide substrate benzyloxycarbonyl-phenylalanine-arginine 7-amido-4-methylcoumarin. This expression and refolding procedure yielded 50 mg of purified, glycosylation-free human procathepsin K from 1 liter of E, coli cell culture and enabled the determination of the structure of human procathepsin K at 2.6 Angstrom resolution. (C) 1999 Academic Press.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 20 条
[1]  
Aibe K, 1996, BIOL PHARM BULL, V19, P1026
[2]  
BACHMAN BJ, 1972, BACTERIOL REV, V4, P525
[3]   MOLECULAR MECHANISMS OF BONE-RESORPTION BY THE OSTEOCLAST [J].
BARON, R .
ANATOMICAL RECORD, 1989, 224 (02) :317-324
[4]  
BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
[5]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[6]   INDEPENDENT DOMAIN FOLDING OF PSEUDOMONAS EXOTOXIN AND SINGLE-CHAIN IMMUNOTOXINS - INFLUENCE OF INTERDOMAIN CONNECTIONS [J].
BRINKMANN, U ;
BUCHNER, J ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3075-3079
[7]   HUMAN CATHEPSIN O2, A NOVEL CYSTEINE PROTEASE HIGHLY EXPRESSED IN OSTEOCLASTOMAS AND OVARY MOLECULAR-CLONING, SEQUENCING AND TISSUE DISTRIBUTION [J].
BROMME, D ;
OKAMOTO, K .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1995, 376 (06) :379-384
[8]   Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases [J].
Carmona, E ;
Dufour, E ;
Plouffe, C ;
Takebe, S ;
Mason, P ;
Mort, JS ;
Menard, R .
BIOCHEMISTRY, 1996, 35 (25) :8149-8157
[9]   Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity [J].
Cygler, M ;
Mort, JS .
BIOCHIMIE, 1997, 79 (11) :645-652
[10]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516